封面
市場調查報告書
商品編碼
1741202

血漿擴張劑市場按產品類型、應用、最終用戶和地區分類

Plasma Expander Market, By Type, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

血漿擴張器市場規模預計在 2025 年為 88.1 億美元,預計到 2032 年將達到 200.9 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 12.5%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 88.1億美元
效能數據 2020-2024 預測期 2025-2032
預測期間:2025年至2032年的年複合成長率 12.50% 2032年價值預測 200.9億美元

過去幾年,全球血漿擴容劑市場顯著成長。血漿擴容劑是手術和創傷期間使用的血液容量替代液,用於增加血管內容量和有效循環血量。當無法輸注血液製品時,血漿擴容劑可透過緊急增加血漿來預防或治療低血容性休克。常見的血漿擴容劑包括白蛋白、聚葡萄糖、羥乙基澱粉和明膠。該市場的成長歸因於外科手術、創傷和事故的增加、老齡人口的成長以及慢性病數量的增加。然而,血漿擴容劑的副作用和高昂的治療費用等因素可能會阻礙市場的成長。

市場動態

全球血漿擴容劑市場主要受創傷、燒燙傷和外科手術日益成長的推動。根據世界衛生組織 (WHO) 的數據,全球每年有超過 450 萬人遭受致命傷害。道路交通事故、暴力、戰爭和其他原因導致了創傷的增加。此外,根據美國燒傷協會的數據,每年有超過 45 萬名燒傷患者在美國專門的燒傷中心接受治療。血漿擴容劑對於治療這種情況下出血性休克至關重要。然而,合成膠體成本高以及過度使用和長期使用引起的副作用等因素正在抑制市場成長。同時,對新型血漿擴容劑配方的持續研究將為預測期間的市場擴張提供機會。

研究的主要特點

  • 本報告對全球血漿擴張器市場進行了詳細分析,並提供了預測期(2025-2032)的市場規模和年複合成長率(CAGR%),假設 2024 年為基準年。
  • 它還揭示了各個領域的潛在商機,並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數,介紹了全球血漿擴張器市場的主要企業概況。
  • 本報告的見解可以幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球血漿擴張器市場報告針對該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過全球血漿擴張器市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 全球慢性病盛行率不斷上升
    • 監管挑戰
    • 新興市場
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 合併、收購和合作

4. 全球血漿擴張劑市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 全球血漿擴張劑市場(按類型),2020-2032

  • 介紹
  • 白蛋白
  • 聚葡萄糖
  • 羥乙基澱粉
  • 明膠
  • 其他

6. 全球血漿擴張劑市場(依產品類型),2020 年至 2032 年

  • 介紹
  • 膠體
  • 合成膨鬆劑

7. 全球血漿擴張劑市場(按應用)2020-2032

  • 介紹
  • 創傷與手術
  • 燒燙傷管理
  • 低血容量
  • 運動醫學
  • 其他

8. 全球血漿擴張劑市場(依最終用戶分類),2020 年至 2032 年

  • 介紹
  • 醫院和診所
  • 門診手術中心
  • 其他

9. 全球血漿擴張劑市場(按地區分類),2020-2032 年

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 東南亞國協
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲
  • 中東和非洲
    • 海灣合作理事會國家
    • 以色列
    • 南非
    • 北非
    • 中部非洲
    • 其他中東地區

第10章 競爭格局

  • 公司簡介
    • Baxter International Inc.
    • Fresenius SE & Co. KGaA
    • CSL Limited
    • Grifols, SA
    • B. Braun Melsungen AG
    • Hikma Pharmaceuticals PLC
    • Octapharma AG
    • Terumo Corporation
    • JW Life Science
    • Haemonetics Corporation
    • Macopharma
    • ADMA Biologics
    • BIoTest AG
    • Takeda Pharmaceutical Company Limited

第 11 章 章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5939

Plasma Expander Market is estimated to be valued at USD 8.81 Bn in 2025 and is expected to reach USD 20.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 8.81 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.50% 2032 Value Projection: USD 20.09 Bn

The global plasma expanders market is witnessing a significant growth over the past few years. Plasma expanders are blood volume replacement fluids used during surgery or trauma to increase intravascular volume of circulating blood and effective circulating volume. They prevent or treat hypovolemic shock by expanding blood plasma on an emergency basis in case when transfusion of blood products is not feasible. Some common plasma expanders include albumin, dextran, hydroxyethyl starch, and gelatin. Growth of this market can be attributed to growing number of surgical procedures, trauma and accident cases, rising geriatric population, and increase in chronic diseases. However, factors such as side effects associated with plasma expanders and high costs of treatment may hamper the market growth.

Market Dynamics

Global plasma expander market is primarily driven by the growing prevalence of trauma, burns, and surgical procedures that often involve significant blood loss. According to the World Health Organization (WHO), over 4.5 MN people suffer fatal injuries annually worldwide. Road accidents, violence, wars, and other such causes have contributed to rising trauma cases. Moreover, according to the American Burn Association, over 450,000 burn injuries are treated in specialized American burn centers each year. Plasma expanders form an integral part of the management of hemorrhagic shock in such conditions. However, factors such as the high costs of synthetic colloids and side effects with excessive or prolonged use restrain the market growth. On the other hand, ongoing research on new plasma expander formulations presents an opportunity for market expansion over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global plasma expander market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global plasma expander market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Baxter International Inc., Fresenius SE & Co. KGaA, CSL Limited, Grifols, S.A., B. Braun Melsungen AG, Hikma Pharmaceuticals PLC, Octapharma AG, Terumo Corporation, JW Life Science, Haemonetics Corporation, Macopharma, ADMA Biologics, Biotest AG, and Takeda Pharmaceutical Company Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global plasma expander market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plasma expander market

Detailed Segmentation:

  • Global Plasma Expander Market, By Type:
    • Albumin
    • Dextran
    • Hydroxyethyl Starch
    • Gelatin
    • Others
  • Global Plasma Expander Market, By Product Type:
    • Colloids
    • Crystalloids
  • Global Plasma Expander Market, By Application:
    • Trauma and Surgical Procedures
    • Burn Management
    • Hypovolemia
    • Sports Medicine
    • Others
  • Global Plasma Expander Market, By End User:
    • Hospitals and Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Plasma Expander Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Baxter International Inc.
    • Fresenius SE & Co. KGaA
    • CSL Limited
    • Grifols, S.A.
    • Braun Melsungen AG
    • Hikma Pharmaceuticals PLC
    • Octapharma AG
    • Terumo Corporation
    • JW Life Science
    • Haemonetics Corporation
    • Macopharma
    • ADMA Biologics
    • Biotest AG
    • Takeda Pharmaceutical Company Limited

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising prevalence of chronic diseases across the world
    • Regulatory challenges
    • Emerging markets
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Plasma Expander Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Plasma Expander Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Albumin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Dextran
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Hydroxyethyl Starch
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Gelatin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Plasma Expander Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Colloids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Synthetic Expanders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Plasma Expander Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Trauma and Surgical Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Burn Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Hypovolemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Sports Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Plasma Expander Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Plasma Expander Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Sub-region2023 and 2032 (%)
    • Y-o-Y Growth Analysis, For Sub-regions, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User2018-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/ Sub-region, 2020-2032, (US$ Bn)
      • GCC Countries
      • Israel
      • South Africa
      • North Africa
      • Central Africa
      • Rest of Middle East

10. Competitive Landscape

  • Company Profile
    • Baxter International Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Fresenius SE & Co. KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • CSL Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Grifols, S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • B. Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Hikma Pharmaceuticals PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Octapharma AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • JW Life Science
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Haemonetics Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Macopharma
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • ADMA Biologics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Biotest AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Takeda Pharmaceutical Company Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst's Views

11. Section

  • References
  • Research Methodology
  • About us